Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis

OBJECTIVE: To assess the onset of ocrelizumab efficacy on brain MRI measures of disease activity in the phase II study in relapsing-remitting multiple sclerosis (RRMS), and relapse rate in the pooled phase III studies in relapsing multiple sclerosis (RMS). METHODS: Brain MRI activity was determined...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neurology
Glavni autori: Barkhof, Frederik, Kappos, Ludwig, Wolinsky, Jerry S., Li, David K.B., Bar-Or, Amit, Hartung, Hans-Peter, Belachew, Shibeshih, Han, Jian, Julian, Laura, Sauter, Annette, Napieralski, Julie, Koendgen, Harold, Hauser, Stephen L.
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2019
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946481/
https://ncbi.nlm.nih.gov/pubmed/31484710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000008189
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items